Novel Adjuvant Strategies for Experimental Malaria and AIDS Vaccines
- 1 August 1993
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 690 (1) , 265-275
- https://doi.org/10.1111/j.1749-6632.1993.tb44015.x
Abstract
Click on the article title to read more.Keywords
This publication has 14 references indexed in Scilit:
- Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challengeVaccine, 1993
- Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvantsImmunobiology, 1993
- Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigensBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.Proceedings of the National Academy of Sciences, 1992
- Liposomes as carriers of antigens and adjuvantsJournal of Immunological Methods, 1991
- Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccineThe Lancet, 1991
- AdjuvantsInternational Reviews of Immunology, 1990
- An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunityJournal of Immunological Methods, 1986
- Induction of AIDS-Like Disease in Macaque Monkeys with T-Cell Tropic Retrovirus STLV-IIIScience, 1985
- Vaccine AdjuvantsClinical Infectious Diseases, 1980